Jennifer Michaelson, Chief Scientific Officer at Cullinan Therapeutics, Inc. (CGEM), sold 416 shares at $12.03 ($5K) on 2026-02-12, disclosed to the SEC on 2026-02-13.
Seasonal sale ($5k) by Chief Scientific Officer — this insider has traded CGEM in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CGEM | SELL | 2026-07-07 | $143K | — | Filing → |
| CGEM | SELL | 2026-05-06 | $117K | — | Filing → |
| CGEM | SELL | 2026-03-09 | $125K | — | Filing → |